ReviewBreathe (Sheffield, England)2024
Stage III NSCLC treatment options: too many choices.
Oke Dimas Asmara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it
ReviewBreathe (Sheffield, England)2024
Oke Dimas Asmara et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.